Charles Thornton Slack, MD | |
1105 Central Expy North, Suite 370, Allen, TX 75013 | |
(214) 495-6464 | |
(214) 509-0273 |
Full Name | Charles Thornton Slack |
---|---|
Gender | Male |
Speciality | Plastic And Reconstructive Surgery |
Experience | 34 Years |
Location | 1105 Central Expy North, Allen, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720038151 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | J0267 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Charles Thornton Slack, MD 1405 Pecan Hollow Trl, Mckinney, TX 75070-9061 Ph: (972) 562-7253 | Charles Thornton Slack, MD 1105 Central Expy North, Suite 370, Allen, TX 75013 Ph: (214) 495-6464 |
News Archive
The insurance commissioner issued controversial rules mandating that insurers explain referral and authorization practices to consumers. Meanwhile, a study details how nearly half the plans available through federal and state exchanges didn't list what drugs patients had access to on their websites and Politico Pro questions whether more states will join the federal exchange.
A study led by the Cedars-Sinai Department of Neurosurgery has identified certain regions in the retina - the lining found in the back of the eye - that are more affected by Alzheimer's disease than other areas.
Most people in the UK do not know that cervical cancer is linked to a common sexually transmitted virus, according to a Cancer Research UK study published on (Monday).
A new study raises the possibility that flies and other insects that encounter nanomaterial "hot spots," or spills, near manufacturing facilities in the future could pick up and transport nanoparticles on their bodies, transferring the particles to other flies or habitats in the environment.
Bathing tumor-ridden livers in chemotherapy increases the length of time certain cancer patients survive without progression of the disease, according to Phase III trial results being presented at the 3rd annual Symposium on Clinical Interventional Oncology (CIO), in collaboration with the International Symposium on Endovascular Therapy (ISET).
› Verified 8 days ago